← Back to Search

Anticoagulation and Thrombosis Point of Care Test(AT-POCT) for Anticoagulation and Thrombosis Test

N/A
Waitlist Available
Led By Ashutosh Chilkoti, PhD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 study day
Awards & highlights

Study Summary

This trial is testing a new, low-cost test to help monitor markers for anticoagulation and thrombosis for patients with advanced heart failure.

Eligible Conditions
  • Anticoagulation and Thrombosis Point of Care Test

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 study day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 study day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Interclass correlation between PT/INR and LDH measurements

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Anticoagulation and Thrombosis Point of Care Test (AT-POCT)Experimental Treatment2 Interventions
Group II: Duke Central Automated Laboratory (DCAL)Active Control2 Interventions

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,384 Previous Clinical Trials
3,427,535 Total Patients Enrolled
Ashutosh Chilkoti, PhDPrincipal InvestigatorDuke University
~0 spots leftby Jul 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top